NEW YORK (AP) - Medical device maker Boston Scientific Corp. said Thursday a Canadian court dismissed a patent infringement lawsuit filed against the company by rival Johnson & Johnson.
New Brunswick, N.J.-based Johnson & Johnson sued Natick, Mass.-based Boston Scientific, claiming its NIR stents infringed two of Johnson & Johnson's patents. The court ruled that one Johnson & Johnson patent was not infringed and the other patent was invalid.
Johnson & Johnson is also suing Boston Scientific over its Express and Taxus Express stents.
Stents are tiny, mesh-wire tubes that prop open arteries after they have been surgically cleared of fatty plaque.
Johnson & Johnson could not immediately be reached for comment late Thursday.
Shares of Boston Scientific rose 26 cents to close at $13.68.
Shares of Johnson & Johnson fell a penny to close at $66.90.

Eritrea is considering five more applications for exploration licences, and will make its decision within the year.
A Swiss pilot strapped on a jet-powered wing and leaped from a plane Wednesday f...
The One Laptop Per Child project is about to find out whether Microsoft Corp., a...


Find the most up to date research from leading investment firms to make the most informed investing decisions
Professional Website Design For Corporate - Get a Free Quote Today